Empery Asset Management, LP 13D and 13G filings for Moleculin Biotech, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-01-20 11:14 am Sale | 2020-12-31 | 13G | Moleculin Biotech, Inc. MBRX | Empery Asset Management, LP | 33,223 4.570% | -8,444 (-20.27%) | Filing |